Press release
Vitiligo Clinical Trials and Pipeline 2024: FDA Approvals, Medication, Treatment market, ROA, MOA and Companies by DelveInsight | AbbVie, Pfizer, Incyte Corporation, Ahammune Biosciences, Amgen
Vitiligo Clinical Trials
"Vitiligo Pipeline Insight, 2024" report by DelveInsight outlines comprehensive insights into the present clinical development scenario and growth prospects across the Vitiligo Market.
The Vitiligo Pipeline report embraces in-depth commercial and clinical assessment of the pipeline products from the pre-clinical developmental phase to the marketed phase. The report also covers a detailed description of the drug, including the mechanism of action of the drug, clinical studies, NDA approvals (if any), and product development activities comprising the technology, collaborations, mergers acquisition, funding, designations, and other product-related details.
Request for sample report @ https://www.delveinsight.com/report-store/vitiligo-pipeline-insight?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=apr
Some of the key takeaways from the Vitiligo Pipeline Report:
• Vitiligo Companies across the globe are diligently working toward developing novel Vitiligo treatment therapies with a considerable amount of success over the years.
• Vitiligo companies working in the treatment market are Clinuvel Pharmaceuticals, Bioniz Therapeutics, TAGCyx Biotechnologies, Temprian Therapeutics, Aclaris Therapeutics, TWi Biotechnology, Dermavant Science, Amgen, Pfizer, Incyte Corporation, Clinuvel Pharmaceuticals, and others, are developing therapies for the Vitiligo treatment
• Emerging Vitiligo therapies in the different phases of clinical trials are- Phimelanotide, BNZ-1, TAGX-0003, TT-01, ATI-1777, AC-1101, Cerdulatinib, AMG 714, Ritlecitinib, Ruxolitinib, Afamelanotide, Crisaborole 2% Topical Ointment, and others are expected to have a significant impact on the Vitiligo market in the coming years.
• In October 2023, Incyte has released favorable long-term extension (LTE) findings from the TruE-V trial, evaluating the safety and effectiveness of Opzelura (ruxolitinib) as a therapy for nonsegmental vitiligo. This study involved patients who had previously shown no improvement from the treatment after 24 weeks of use.
• AnaptysBio is entering a Phase 1 study with healthy volunteers for their ANB030 (Anti-PD-1 Agonist) program; top-line data are expected in mid-2021. Phase 2 clinical studies for vitiligo and alopecia areata are planned for Q4 2021, assuming all goes according to plan.
Vitiligo Overview
A complicated pigment condition affecting the skin, hair, and occasionally the mucous membranes is called vitiligo. Though it can occur on any part of the skin, vitiligo usually affects the hands, neck, and face. Clinically, vitiligo manifests as milk-white, irregularly oval skin patches that start out small and grow over time.
Get a Free Sample PDF Report to know more about Vitiligo Pipeline Therapeutic Assessment - https://www.delveinsight.com/sample-request/vitiligo-pipeline-insight?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=apr
Emerging Vitiligo Drugs Under Different Phases of Clinical Development Include:
• Phimelanotide: Clinuvel Pharmaceuticals
• BNZ-1: Bioniz Therapeutics
• TAGX-0003: TAGCyx Biotechnologies
• TT-01: Temprian Therapeutics
• ATI-1777: Aclaris Therapeutics
• AC-1101: TWi Biotechnology
• Cerdulatinib: Dermavant Science
• AMG 714: Amgen
• Ritlecitinib: Pfizer
• Ruxolitinib: Incyte Corporation
• Afamelanotide: Clinuvel Pharmaceuticals Limited
• Crisaborole 2% Topical Ointment: Pfizer
Vitiligo Route of Administration
Vitiligo pipeline report provides the therapeutic assessment of the pipeline drugs by the Route of Administration. Products have been categorized under various ROAs, such as
• Oral
• Parenteral
• Intravitreal
• Subretinal
• Topical.
• Molecule Type
Request for sample report @ https://www.delveinsight.com/sample-request/vitiligo-pipeline-insight?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=apr
Vitiligo Molecule Type
Vitiligo Products have been categorized under various Molecule types, such as
• Monoclonal Antibody
• Peptides
• Polymer
• Small molecule
• Gene therapy
• Product Type
Vitiligo Pipeline Therapeutics Assessment
• Vitiligo Assessment by Product Type
• Vitiligo By Stage and Product Type
• Vitiligo Assessment by Route of Administration
• Vitiligo By Stage and Route of Administration
• Vitiligo Assessment by Molecule Type
• Vitiligo by Stage and Molecule Type
DelveInsight's Vitiligo Report covers around 22+ products under different phases of clinical development like
• Late-stage products (Phase III)
• Mid-stage products (Phase II)
• Early-stage product (Phase I)
• Pre-clinical and Discovery stage candidates
• Discontinued & Inactive candidates
• Route of Administration
Further Vitiligo product details are provided in the report. Download the Vitiligo pipeline report to learn more about the emerging Vitiligo therapies - https://www.delveinsight.com/report-store/vitiligo-pipeline-insight?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=apr
Some of the key companies in the Vitiligo Therapeutics Market include:
Key companies developing therapies for Vitiligo are - Dermavant Sciences, Incyte Corporation, TWi Biotechnology, Aclaris Therapeutics, Dermira, Amgen, Pfizer, Arcutis Biotherapeutics, AnaptysBio, Bioniz Therapeutics, among others.
Vitiligo Pipeline Analysis:
The Vitiligo pipeline report provides insights into
• The report provides detailed insights about companies that are developing therapies for the treatment of Vitiligo with aggregate therapies developed by each company for the same.
• It accesses the Different therapeutic candidates segmented into early-stage, mid-stage, and late-stage of development for Vitiligo Treatment.
• Vitiligo key companies are involved in targeted therapeutics development with respective active and inactive (dormant or discontinued) projects.
• Vitiligo Drugs under development based on the stage of development, route of administration, target receptor, monotherapy or combination therapy, a different mechanism of action, and molecular type.
• Detailed analysis of collaborations (company-company collaborations and company-academia collaborations), licensing agreement and financing details for future advancement of the Vitiligo market.
The report is built using data and information traced from the researcher's proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations, and featured press releases from company/university websites and industry-specific third-party sources, etc.
Download Sample PDF Report to know more about Vitiligo drugs and therapies - https://www.delveinsight.com/sample-request/vitiligo-pipeline-insight?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=apr
Vitiligo Pipeline Market Drivers
Increasing awareness, demand of novel therapies, large patient pool and better healthcare infrastructure are some of the important factors that are fueling the Vitiligo Market.
Vitiligo Pipeline Market Barriers
However, patient compliance, chronic nature of disease and long term therapy, lack of adequate financial assistance & stringent regulatory procedure and other factors are creating obstacles in the Vitiligo Market growth.
Scope of Vitiligo Pipeline Drug Insight
• Coverage: Global
• Key Vitiligo Companies: Clinuvel Pharmaceuticals, Bioniz Therapeutics, TAGCyx Biotechnologies, Temprian Therapeutics, Aclaris Therapeutics, TWi Biotechnology, Dermavant Science, Amgen, Pfizer, Incyte Corporation, Clinuvel Pharmaceuticals, and others
• Key Vitiligo Therapies: Phimelanotide, BNZ-1, TAGX-0003, TT-01, ATI-1777, AC-1101, Cerdulatinib, AMG 714, Ritlecitinib, Ruxolitinib, Afamelanotide, Crisaborole 2% Topical Ointment, and others
• Vitiligo Therapeutic Assessment: Vitiligo current marketed and Vitiligo emerging therapies
• Vitiligo Market Dynamics: Vitiligo market drivers and Vitiligo market barriers
Request for Sample PDF Report for Vitiligo Pipeline Assessment and clinical trials - https://www.delveinsight.com/sample-request/vitiligo-pipeline-insight?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=apr
Table of Contents
1. Vitiligo Report Introduction
2. Vitiligo Executive Summary
3. Vitiligo Overview
4. Vitiligo- Analytical Perspective In-depth Commercial Assessment
5. Vitiligo Pipeline Therapeutics
6. Vitiligo Late Stage Products (Phase II/III)
7. Vitiligo Mid Stage Products (Phase II)
8. Vitiligo Early Stage Products (Phase I)
9. Vitiligo Preclinical Stage Products
10. Vitiligo Therapeutics Assessment
11. Vitiligo Inactive Products
12. Company-University Collaborations (Licensing/Partnering) Analysis
13. Vitiligo Key Companies
14. Vitiligo Key Products
15. Vitiligo Unmet Needs
16 . Vitiligo Market Drivers and Barriers
17. Vitiligo Future Perspectives and Conclusion
18. Vitiligo Analyst Views
19. Appendix
20. About DelveInsight
Trending Reports:
• Allergic Rhinitis Market: https://www.delveinsight.com/report-store/allergic-rhinitis-market
• Alopecia Areata Market: https://www.delveinsight.com/report-store/alopecia-areata-market
• Alopecia Market: https://www.delveinsight.com/report-store/alopecia-areata-market
• Alpha-mannosidosis Market: https://www.delveinsight.com/report-store/alpha-mannosidosis-market
• Alstrom Syndrome Market: https://www.delveinsight.com/report-store/alstrom-syndrome-market
• Anaphylaxis Market: https://www.delveinsight.com/report-store/anaphylaxis-market
• Angioedema Market: https://www.delveinsight.com/report-store/hereditary-angioedema-market
• Anterior Cruciate Ligament Injuries Market: https://www.delveinsight.com/report-store/anterior-cruciate-ligament-injuries-market
• Apheresis Market: https://www.delveinsight.com/report-store/apheresis-market
• Arteriovenous Fistula Market: https://www.delveinsight.com/report-store/arteriovenous-fistula-market
• Arthroscopic Shavers Market: https://www.delveinsight.com/report-store/arthroscopic-shavers-market
• Artificial Iris Market: https://www.delveinsight.com/report-store/artificial-iris-market
• Artificial Kidney Market: https://www.delveinsight.com/report-store/artificial-kidney-market
• Asphyxia Market: https://www.delveinsight.com/report-store/asphyxia-market
• Astigmatism Market: https://www.delveinsight.com/report-store/astigmatism-market
• Atherectomy Devices Market: https://www.delveinsight.com/report-store/atherectomy-devices-market
• Atypical Hemolytic Uremic Syndrome Ahus Market: https://www.delveinsight.com/report-store/atypical-hemolytic-uremic-syndrome-ahus-market
• Atypical Teratoid Rhabdoid Tumors Market: https://www.delveinsight.com/report-store/atypical-teratoid-rhabdoid-tumors-market
• Automated External Defibrillators Market: https://www.delveinsight.com/report-store/automated-external-defibrillator-aed-market
• Bacterial Skin Diseases Market: https://www.delveinsight.com/report-store/acute-bacterial-skin-and-skin-structure-infections-market
• Bartonellosis Market: https://www.delveinsight.com/report-store/bartonellosis-market
• Benefits Of Robotics In Healthcare: https://www.delveinsight.com/blog/robotics-in-healthcare
• Biliary Tumor Market: https://www.delveinsight.com/report-store/biliary-tract-cancers-btcs-market
• Bipolar Depression Market: https://www.delveinsight.com/report-store/bipolar-disorder-manic-depression-market
• Bladder Cancer Market: https://www.delveinsight.com/report-store/non-muscle-invasive-bladder-cancer-market
• Bladder Pain Syndrome Market: https://www.delveinsight.com/report-store/interstitial-cystitis-market
• Blood Gas And Electrolyte Analyzers Market: https://www.delveinsight.com/report-store/blood-gas-and-electrolyte-analyzers-market
Contact Us:
Ankit Nigam
Manager Marketing
info@delveinsight.com
+14699457679
https://www.delveinsight.com/consulting/competitive-intelligence-services
Case study: https://www.delveinsight.com/case-study/hematological-malignancy-competitive-intelligence
About DelveInsight
DelveInsight is a leading Life Science market research and business consulting company recognized for its off-the-shelf syndicated market research reports and customized solutions to firms in the healthcare sector.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Vitiligo Clinical Trials and Pipeline 2024: FDA Approvals, Medication, Treatment market, ROA, MOA and Companies by DelveInsight | AbbVie, Pfizer, Incyte Corporation, Ahammune Biosciences, Amgen here
News-ID: 3730022 • Views: …
More Releases from DelveInsight Business Research
Usher Syndrome Pipeline Analysis 2024: EMA, PDMA, FDA Approvals, Clinical Trials …
(Albany, United States) As per DelveInsight's assessment, globally, Usher Syndrome pipeline constitutes 5+ key companies continuously working towards developing 7+ Usher Syndrome treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight.
"Usher Syndrome Pipeline Insight, 2024" report by DelveInsight outlines comprehensive insights into the present clinical development scenario and growth prospects across the Usher Syndrome Market.
The Usher Syndrome Pipeline report embraces in-depth commercial…
Renal Tubular Acidosis Clinical Trials 2024: EMA, PDMA, FDA Approvals, Medicatio …
(Albany, United States) As per DelveInsight's assessment, globally, Renal Tubular Acidosis pipeline constitutes 5+ key companies continuously working towards developing 5+ Renal Tubular Acidosis treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight.
"Renal Tubular Acidosis Pipeline Insight, 2024" report by DelveInsight outlines comprehensive insights into the present clinical development scenario and growth prospects across the Renal Tubular Acidosis Market.
The Renal Tubular Acidosis…
Venous Thromboembolism Clinical Trials 2024: EMA, PDMA, FDA Approvals, Medicatio …
(Albany, United States) As per DelveInsight's assessment, globally, Venous Thromboembolism pipeline constitutes 10+ key companies continuously working towards developing 10+ Venous Thromboembolism treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight.
"Venous Thromboembolism Pipeline Insight, 2024" report by DelveInsight outlines comprehensive insights into the present clinical development scenario and growth prospects across the Venous Thromboembolism Market.
The Venous Thromboembolism Pipeline report embraces in-depth commercial…
Exocrine Pancreatic Insufficiency Clinical Trials 2024: EMA, PDMA, FDA Approvals …
(Albany, United States) As per DelveInsight's assessment, globally, Exocrine Pancreatic Insufficiency pipeline constitutes 5+ key companies continuously working towards developing 5+ Exocrine Pancreatic Insufficiency treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight.
"Exocrine Pancreatic Insufficiency Pipeline Insight, 2024" report by DelveInsight outlines comprehensive insights into the present clinical development scenario and growth prospects across the Exocrine Pancreatic Insufficiency Market.
The Exocrine Pancreatic Insufficiency…
More Releases for Vitiligo
Vitiligo - Drug Pipeline Landscape, 2022
Vitiligo is a chronic disorder that causes patches of skin to lose pigment or color, when melanocytes are attacked and destroyed, causing the skin to turn a milky-white color. There are two types of vitiligo such as nonsegmental or generalized vitiligo and segmental vitiligo. Nonsegmental or generalized vitiligo happens when the white patches appear symmetrically on both sides of body, such as on both hands or both knees. Segmental vitiligo…
Vitiligo Treatment Market: Rising Impressive Business Opportunities Analysis For …
Vitiligo Treatment Market Report 2022: Industry aims to provide an overview of the industry through detailed market segmentation. The report offers thorough information about the overview and scope of the market along with its drivers, restraints, and trends. This report is designed to include both qualitative and quantitative aspects of the industry in each region and country participating in the study.
Get a Sample PDF of the Report @ https://impeccablemarketresearch.com/enquiry/request-sample-pdf/14636671?utm_source=Openpr&utm_medium=Shubhamko
…
Global Vitiligo Drug Market Analysis And Study 2017
Qyresearchreports include new market research report "Global Vitiligo Drug Market Research Report 2017" to its huge collection of research reports.
The exhaustive report here gathers various viewpoints having a place with the overall Vitiligo Drug marketplace which verbalizes the prevailing-day records and destiny exposures as regards to the dynamic forces at play. The prime motive for the examination report is to offer the endorser with an expansive format and make available…
Health Cure Networks Offers Permanent Vitiligo Cure Solutions
Irvine, CA, February 14, 2012: Health Cure Networks believes in permanent cure for vitiligo. The solutions provided by them have received Thumbs-Up from their patients. The company is in this industry for almost a decade now, which is why they are rated highly. Among other services they provide, it is their outpatient treatment procedures that has benefitted scores of patients worldwide.
If you are thinking about Vitiligo Cure, approaching…
Vitiligo Skin Disorder
Vitiligo Skin Disorder
Vitiligo skin disorder is a skin condition in which white patches on the skin are formed due to malfunctioning of melanocytes, cells that promote pigmentation. http://www.curevitiligooil.com/Vitiligo-Skin-Disorder.htmlThe start of this disease and the grimness of pigment loss vary from person to person. People who have light skin usually witness the loss of pigment in summers because the contrast between depigmented skin and sunburned skin appears distinctive. On the other…
Vitiligo Symptoms
Vitiligo produces macules which are small areas of different skin color. The skin disorder may also produce patches which are flat, pale or white and can't be felt with fingers. (http://www.curevitiligooil.com/Vitiligo-Symptoms.html). These marks frequently expand to form very large, irregularly-shaped areas with no pigmentation. Typically, these are painless and do not itch. The cause of vitiligo symptoms is not known, but autoimmunity may be a factor. Since it is a…
